TerrAscend (OTCMKTS:TSNDF – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.04, Zacks reports. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%.
TerrAscend Stock Performance
OTCMKTS:TSNDF opened at $0.41 on Friday. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. The company’s fifty day moving average price is $0.58 and its 200-day moving average price is $0.88. TerrAscend has a 1-year low of $0.38 and a 1-year high of $2.20.
Wall Street Analyst Weigh In
Separately, Atb Cap Markets lowered shares of TerrAscend from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th.
About TerrAscend
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
See Also
- Five stocks we like better than TerrAscend
- Consumer Staples Stocks, Explained
- Warren Buffett Swaps VOO for This Reliable Dividend Stock
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Palantir Bears Sell the Headlines—Time for Bulls to Buy?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Beaten Down Stocks With Quality Fundamentals and Outlook
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
